English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Pancreatic cancer, often called the “silent killer,” is the twelfth most common cancer in Canada, with an estimated 4600 new cases in 20121. Surpassing prostate cancer, pancreatic cancer is also the fourth leading cause of cancer-related death in Canada, with an estimated 4300 deaths in 20121. Smoking, obesity, diabetes, and genetic predisposition are all known risk factors for pancreatic cancer. Currently, no early detection method and no effective treatment are available for pancreatic cancer2. Of all patients diagnosed with pancreatic cancer, 75% die within the first year, most within the first 3–6 months2. The objective of the present article is to highlight the outcomes of this highly fatal cancer. Further details on the results and on the methodologies used can be found in the 2012 Cancer System Performance Report released by the Canadian Partnership Against Cancer as part of the system performance initiative.

Provincial rates and time trends in pancreatic cancer outcomes